News on Tanabe Seiyaku Co.%2C Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Tanabe Seiyaku Co.%2C Ltd news from BioPortfolio.com Wed, 10 Feb 2010 05:22:02 GMT en Watson Confirms Filing of FDA Application for Generic Lidodermhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957093&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957093&THISHREF=http://c.moreover.com/click/here.pl%3fz2494828969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957093&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957093&THISHREF=http://c.moreover.com/click/here.pl%3fz2494828969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Tanabe Sets New Course For La Jolla Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954638&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954638&THISHREF=http://c.moreover.com/click/here.pl%3fz2492997058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954638&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954638&THISHREF=http://c.moreover.com/click/here.pl%3fz2492997058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrugs.com: Tanabe Sets New Course For La Jolla Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954210&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954210&THISHREF=http://c.moreover.com/click/here.pl%3fz2492555902%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954210&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954210&THISHREF=http://c.moreover.com/click/here.pl%3fz2492555902%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Tanabe sets new course for La Jolla laboratories [The San Diego Union-Tribune]http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952243&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952243&THISHREF=http://c.moreover.com/click/here.pl%3fz2490674586%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952243&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952243&THISHREF=http://c.moreover.com/click/here.pl%3fz2490674586%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Tanabe cuts jobs as it focuses on biologicshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949652&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949652&THISHREF=http://c.moreover.com/click/here.pl%3fz2489230997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949652&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949652&THISHREF=http://c.moreover.com/click/here.pl%3fz2489230997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: Endo Pharmaceuticals Announces Receipt of Paragraph IV Certificationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946507&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946507&THISHREF=http://c.moreover.com/click/here.pl%3fz2487578554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946507&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946507&THISHREF=http://c.moreover.com/click/here.pl%3fz2487578554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: Endo Pharma's Lidoderm patch gets generic threathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932385&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932385&THISHREF=http://c.moreover.com/click/here.pl%3fz2481084681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932385&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932385&THISHREF=http://c.moreover.com/click/here.pl%3fz2481084681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: Watson Confirms Filing of FDA Application for Generic Lidoderm(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3936076&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3936076&THISHREF=http://c.moreover.com/click/here.pl%3fz2482830185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3936076&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3936076&THISHREF=http://c.moreover.com/click/here.pl%3fz2482830185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933242&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933242&THISHREF=http://c.moreover.com/click/here.pl%3fz2481578246%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933242&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933242&THISHREF=http://c.moreover.com/click/here.pl%3fz2481578246%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Watson Pharmaceuticals confirms the filing of ANDA with FDA for Lidodermhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932860&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932860&THISHREF=http://c.moreover.com/click/here.pl%3fz2481381403%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932860&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932860&THISHREF=http://c.moreover.com/click/here.pl%3fz2481381403%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Watson Confirms Filing of FDA Application for Generic Lidoderm(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932255&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932255&THISHREF=http://c.moreover.com/click/here.pl%3fz2480981077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932255&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932255&THISHREF=http://c.moreover.com/click/here.pl%3fz2480981077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Endo Pharmaceuticals Announces Receipt of Paragraph IV Certificationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932131&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932131&THISHREF=http://c.moreover.com/click/here.pl%3fz2480907293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932131&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932131&THISHREF=http://c.moreover.com/click/here.pl%3fz2480907293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: UPDATE 1-Endo Pharma's Lidoderm patch gets generic threathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929053&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929053&THISHREF=http://c.moreover.com/click/here.pl%3fz2479458180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929053&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929053&THISHREF=http://c.moreover.com/click/here.pl%3fz2479458180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: /C O R R E C T I O N Watson Pharmaceuticals, Inc./http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931750&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931750&THISHREF=http://c.moreover.com/click/here.pl%3fz2480685016%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931750&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931750&THISHREF=http://c.moreover.com/click/here.pl%3fz2480685016%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Endo Pharmaceuticals Announces Receipt of Paragraph IV Certificationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931748&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931748&THISHREF=http://c.moreover.com/click/here.pl%3fz2480683967%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931748&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tanabe%20Seiyaku%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931748&THISHREF=http://c.moreover.com/click/here.pl%3fz2480683967%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: